Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates (Q83987531)
Jump to navigation
Jump to search
scientific article published on 01 May 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates |
scientific article published on 01 May 2006 |
Statements
Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates (English)
Lance A Smith
Michael J Jackson
Louisa Johnston
Mikko Kuoppamaki
Sarah Rose
Ghassan Al-Barghouthy
Susanna Del Signore